Pharmaceutical Executive March 18, 2024
Miranda Schmalfuhs

In this Pharmaceutical Executive video interview, Kaveh Vahdat, Founder and President of RiseOpp, discusses the impact AI will have on thelong-term well-being of founders and CEOs.

As AI continues to become an increasingly valuable tool at the C-suite level, both in and out of office, how do you envision this shift impacting the long-term well-being and sustainability of founders and CEOs?

I think in the short term is going to help in the long term, I have to think about it and I’m going to tell you about my perspective upon it. So, in the short term, what’s going to happen is that CEOs are repeat jobs, a lot of reporting, presentations, a lot of things that they need attention,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Employer, Technology, Trends
Research Shows Generative AI In The EHR Can Work Well, But Only With Human Oversight
Ellison Institute of Technology campus in Oxford to focus on HealthTech as one of 4 key areas of technological innovation
How to prepare your workforce to think like AI pros
Warren Buffett warns of AI risks
UK sets out position on regulating AI as a medical device

Share This Article